Who Are We
Lotus Regenerative and Medical Technologies, LLC (LRMT) specializes in the development and commercialization of innovative medical therapies and medical devices, with a strong focus in the emerging field of cell Therapy.
LRMT’s visionary and dedicated team of business leaders, medical experts and scientists are committed to bring transformative medical therapies from the lab to the patient’s bedside. LRMT’s Executive Leadership Team with their Scientific Advisory Board and consulting members ensure ethical business practices are imbibed at all levels of the organisation.
R. Vijayanagar, M.D, F.A.C.S, F.A.C.C, F.A.C.P: Founder and Chairman
Dr. Vijay, as he is popularly known, is a renowned cardiac and thoracic surgeon credited for performing the first heart transplant at Tampa General Hospital in 1985. He is a pioneer in the field of saving lives. He is board certified in general surgery and thoracic and cardiovascular surgery. He is a Fellow of the American College of Cardiology, the American College of Surgeons, and the American College of Chest Physicians. Among his many professional memberships are the American Medical Association, the Society of Thoracic Surgeons, the International Society for Cardiovascular Surgery, and the International Society for Heart Transplantation. Dr. Vijayanagar served as a member on the Advisory Committee to the Director, National Institutes of Health, from 2003-2006, and is a recipient of the Ellis Island Medal of Honor
Anil Kumar, M.D, Chief Operating Officer
Dr. Kumar is responsible for overseeing operations, research and business development of the company. Directs and implements an organization's research and development policies, objectives, and initiatives. Ensures research and development activities will maintain an organization's competitive position and profitability. Plans and organizes the daily operations of the research unit, to include protocol and systems, budgeting, staffing, and grant/contract administration. Assists in all aspects of study design, implementation, and administration, ensuring compliance with HRRC (IRB) requirements, Federal/State regulations, and grant and/or contract parameters. Assists in the submission of protocols for clinical trials with the FDA, Pre-IND and IND Submissions, Facility registrations with maintenance with the FDA, the center for biologics evaluation and research (CBER).
A veteran in administrative medicine, he has over 20 years of experience in the healthcare industry.
Carley Glass, Ph.D : Scientific Advisor
Dr. Glass, completed MS in Molecular Biology in 2010 and then went on to do her Ph.D in Biomedical sciences from the University Of Central Florida in 2011. Her area of specialization includes cardiovascular and stem cell research